Rethinking Clozapine Monitoring: 22 Years of Data
Psychopharmacology and Psychiatry Updates · Psychopharmacology Institute
April 6, 202513m 7s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we explore a landmark Finnish study examining the long-term risk of agranulocytosis in patients taking clozapine. The research followed 62,000 patients over 22 years, providing crucial data about this rare but serious side effect. Could these findings change how we approach clozapine prescribing and monitoring requirements?
Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.